Current research is focusing on experimentally verifying peiminine’s regulatory effect on the PI3K–AKT signaling pathway, while future studies will prioritize elucidating the detailed mechanisms underlying its anti-lung cancer efficacy and identifying clearer therapeutic targets. Here, AKT1 is linked to lung carcinoma.